| Name | Title | Contact Details |
|---|
First Continental International (NJ) is a Rochelle Park, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Excelera is a national network of academic medical centers and integrated delivery networks with specialty pharmacy capabilities. Excelera supports its members by using sophisticated data management, reporting and analytical capabilities; secures access to limited distribution specialty pharmaceuticals; and provides clinical care protocols and best practices. Excelera is grounded in the simple premise that health systems, along with their specialist physicians, are best equipped to produce optimal health and financial outcomes for complex patients because they are the central hub for coordinating and integrating care needs, managing the electronic medical record, and providing a high-touch local service.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Assisted Living at Spring Oak is a Lanoka Harbor, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medical Imaging Applications is a Coralville, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.